XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 48,325,444 $ 37,853,947
Marketable securities 2,500,089 15,014,750
Accounts receivable 4,453,391 13,327,364
Prepaid and other current assets 3,881,014 2,962,903
Total current assets 59,159,938 69,158,964
Other assets    
Property and equipment - net 70,553 78,107
Right of use assets - operating leases 874,620 999,567
Patents and patent applications - net 11,285 11,628
Other non-current assets 202,422 179,532
Total assets 60,318,818 70,427,798
Current liabilities    
Accounts payable and accrued expenses 5,318,645 3,369,848
Accrued salaries and wages 759,385 201,254
Royalty payable 426,257 2,920,148
Deferred revenue 0 16,618
Operating leases 283,320 337,690
Total current liabilities 6,787,607 6,845,558
Long-term liabilities    
Operating leases - long term 608,019 673,347
Convertible debt, net of unamortized discount 13,659,946 16,069,085
Total long-term liabilities 14,267,965 16,742,432
Total liabilities 21,055,572 23,587,990
Stockholders' equity    
Common stock; par value $0.001; 200,000,000 shares authorized; 5,079,605 and 4,909,846 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 5,080 4,910
Additional paid-in capital 113,208,236 108,569,988
Accumulated other comprehensive loss (81,965) (54,815)
Accumulated deficit (73,868,105) (61,680,275)
Total stockholders' equity 39,263,246 46,839,808
Total liabilities and stockholders' equity $ 60,318,818 $ 70,427,798